PLSE
Pulse Biosciences, Inc. · Healthcare
Chief Commercial Officer Kevin Patrick Danahy sold $1.4M of Pulse Biosciences, Inc.
Sold$1,410,600
$23.51Price
60,000Shares
−58%Stake
What PLSE did after the filing
- The stock from Tue, Feb 17 close, $23.67
- −8.8%
- S&P 500, same days
- −4.8%
Measured over 30 trading days, to the Mar 31 close.
Traded Thu, Feb 12. Filed Tue, Feb 17, 3:47 PM ET, during the session. Returns use the Feb 17 close and the Mar 31 close. Not investment advice.